Investing Ideas
/
Swedish Pharmaceuticals & Biotech Potentially Undervalued Companies

Swedish Pharmaceuticals & Biotech Potentially Undervalued Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

3 new

Companies with a Value score of at least 3, ordered by Value score

30 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
SPRINT Sprint Bioscience	SEK 1.60	1.7%	16.4%	SEK 111.4m	SEK 3.00	PS1.8x	S27.6%	n/a
NEWBRY Newbury Pharmaceuticals	SEK 3.42	-2.3%	-9.3%	SEK 84.9m	SEK 8.00	PS2.3x	E130.0%	n/a
DVYSR Devyser Diagnostics	SEK 117.00	-4.1%	46.3%	SEK 1.9b	SEK 158.82	PS9.8x	E118.8%	n/a
AZN AstraZeneca	SEK 1,447.00	-2.4%	7.0%	SEK 162.9b	SEK 1,948.45	PE31.4x	E18.2%	2.2%
CAMX Camurus	SEK 574.50	2.0%	12.4%	SEK 33.2b	SEK 745.00	PE126.9x	E83.1%	n/a
CLBIO Corline Biomedical	SEK 8.76	9.8%	-37.9%	SEK 178.8m	SEK 23.00	PS8x	E114.7%	n/a
EEVIA New Eevia Health Oyj	SEK 0.17	-46.9%	-83.0%	SEK 10.9m	n/a	PS0.7x	n/a	n/a
SPAGO Spago Nanomedical	SEK 0.19	6.8%	-37.2%	SEK 61.3m	SEK 0.80	PS9.4x	E119.8%	n/a
AROC AroCell	SEK 0.38	-3.5%	-12.4%	SEK 92.6m	SEK 0.90	PS1.7x	E25.6%	n/a
KLAR Klaria Pharma Holding AB (publ.)	SEK 0.29	-28.5%	-46.8%	SEK 45.3m	SEK 0.70	PB3.2x	E89.7%	n/a
VITR Vitrolife	SEK 214.40	-0.7%	12.4%	SEK 28.7b	SEK 273.33	PS8.2x	E96.8%	0.5%
MAGLE Magle Chemoswed Holding	SEK 33.20	0%	30.7%	SEK 599.9m	SEK 48.00	PE36.5x	S27.0%	n/a
SYNACT SynAct Pharma	SEK 9.69	-11.1%	27.1%	SEK 398.5m	SEK 16.00	PB2.4x	E99.2%	n/a
SOBI BTA Swedish Orphan Biovitrum	SEK 221.00	0.5%	n/a	SEK 74.3b	SEK 288.15	PE23.8x	E20.6%	n/a
BIOT Biotage	SEK 158.80	-3.8%	24.5%	SEK 12.5b	SEK 202.67	PE49.5x	E19.5%	1.0%
SOBI Swedish Orphan Biovitrum	SEK 310.40	-2.1%	17.5%	SEK 106.7b	SEK 359.73	PE30.3x	E19.8%	n/a
MOB Moberg Pharma	SEK 11.28	21.7%	-17.1%	SEK 477.2m	SEK 9.50	PS60x	E66.5%	n/a
CHOSA Chosa Oncology	SEK 0.53	0%	-59.2%	SEK 34.4m	n/a	PB2x	n/a	n/a
ACE Ascelia Pharma	SEK 3.10	-6.9%	-15.9%	SEK 305.1m	SEK 8.25	PB2.8x	E47.2%	n/a
ISAB Inhalation Sciences Sweden	SEK 4.34	0%	24.4%	SEK 65.8m	SEK 16.50	PS3.8x	S59.5%	n/a
ONCO BTA Oncopeptides	SEK 3.00	11.5%	n/a	SEK 717.3m	SEK 5.87	PS20.4x	E32.2%	n/a
LPGO Lipigon Pharmaceuticals	SEK 0.17	-11.5%	-63.2%	SEK 26.6m	SEK 0.90	PS2.8x	E139.5%	n/a
ORX Orexo	SEK 20.80	18.9%	27.8%	SEK 757.4m	SEK 19.75	PS1.2x	E45.6%	n/a
XBRANE Xbrane Biopharma	SEK 0.16	-5.2%	-98.1%	SEK 260.0m	SEK 0.45	PS1.3x	E130.2%	n/a

Page 1 of 2